Hypoglycemia Panel (Sulfonylureas), Serum or Plasma
Use
This test is used as a preferred method to evaluate if the etiology of hypoglycemia is due to sulfonylurea ingestion. Sulfonylureas are a class of medications often used to manage blood sugar levels in type 2 diabetes, and their presence in blood can indicate accidental or intentional ingestion.
Special Instructions
Not provided.
Limitations
The test is performed through a non-ARUP laboratory using High Performance Liquid Chromatography-Tandem Mass Spectrometry. Limitations may include interferences from substances or metabolites not targeted by the assay. Additionally, the transport and storage conditions must be followed strictly to maintain sample integrity.
New York Approved
Methodology
Mass Spectrometry
Biomarkers
LOINC Codes
- 3474-4 - chlorproPAMIDE SerPl-mCnc
- 40465-7 - Glimepiride SerPl-mCnc
- 10539-5 - glipiZIDE SerPl-mCnc
- 10540-3 - glyBURIDE SerPl-mCnc
- 49702-4 - Nateglinide SerPl-mCnc
- 38542-7 - Repaglinide SerPl-mCnc
- 9629-7 - TOLAZamide SerPl-mCnc
- 4061-8 - TOLBUTamide SerPl-mCnc
Result Turnaround Time
8-11 days
Related Documents
For more information, please review the documents below
Specimen
Serum
Volume
1 mL
Minimum Volume
0.3 mL
Container
ARUP standard transport tube
Collection Instructions
Separate from cells ASAP or within 2 hours of collection. Transfer 1 mL serum or plasma to an ARUP standard transport tube.
Causes for Rejection
Separator tubes
Stability Requirements
| Temperature | Period |
|---|---|
| Room Temperature | 48 hours |
| Refrigerated | 28 days |
| Frozen | 24 months |
Other tests from different labs that may be relevant